Industries > Pharma > Top 25 Antibiotic Drugs Manufacturers 2018

Top 25 Antibiotic Drugs Manufacturers 2018

US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others

PUBLISHED: 12 June 2018
PAGES: 250
PRODUCT CODE: PHA0316

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

Visiongain forecasts the antibiotic drugs market to increase to $ 43,841.7m in 2022. The market is estimated to grow at a CAGR of 3.4% between 2022 and 2028. In 2017, Pfizer held the largest market share of the antibiotic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 250-page report you will receive 181 tables and 111 figures– all unavailable elsewhere.

The 250-page report provides clear detailed insight into the top 25 antibiotic drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Antibiotic Drugs Market Forecast from 2018-2028, further segmented by type:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

Top 25 Antibiotic Drugs Manufacturers 2018

• This report provides analysis of the leading antibiotic drugs manufacturers in the US, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Pfizer: Sulperazon, Unasyn, Zithromax, Dalacin, Merrem/Meropen, Zyvox, Tygacil, Others
• Merck & Co.: Cubicin, Invanz, Avelox, Primaxin, Others
• Johnson & Johnson: Zeftera, Sirturo, Others
• Cubist Pharmaceuticals: Cubicin, Sivextro Oral
• Abbott Laboratories: Baxin, Others
• Eli Lilly & Co.: Vancocin, Ceclor
• Melinta Therapeutics, Inc: Orbactiv, Others

• This report provides analysis of the leading antibiotic drugs manufacturers in Europe, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Novartis: Vigamox, Ciprodex, TOBI Podhaler, Cubicin
• GlaxoSmithKline: Ceftin/Zinnat, Augmentin IR, Amoxil, Others
• Bayer: Avelox, Cipro/Cirpobay
• Allergan: Zinforo/Teflaro, Dalbavancin, Others
• Roche: Rocephin
• Sanofi: Targocid, Others
• STADA Arzneimittel: Amoxicillin, Diclofenac Sodium

• This report provides analysis of the leading antibiotic drugs manufacturers in Japan, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Shionogi & Co., Ltd.: Flomox/Flumarin, Others
• Taisho Pharmaceutical Holdings: Geninax, Biaxin/Clarith, Zosyn/Tazocin
• Daiichi Sankyo: Cravit, Levaquin, Others
• Meiji Holdings Company, Ltd.: Meiact/Spectracef, Others
• Astellas Pharma: Dificid, Others

• This report provides analysis of the leading antibiotic drugs manufacturers in other countries, including forecasts from 2018-2028 of the company’s antibiotic drugs revenue, where possible:
• Sun Pharmaceutical Industries: Ciprofloxacin Hydrochloride, Others
• Cipla: Amoxicillin, Others
• Lupin: Cefixime, Cephalexin, Others
• Shanghai Pharmaceuticals Holding: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
• Dr. Reddy’s Laboratories: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
• TaiGen Biotechnology: Taigexyn

Visiongain’s study is intended for anyone requiring commercial analyses for the top 25 antibiotic drugs manufacturers. You find data, trends and predictions.

Buy our report today Top 25 Antibiotic Drugs Manufacturers 2018: US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 25 Antibiotic Drugs Manufacturers 2018


Download sample pages

Complete the form below to download your free sample pages for Top 25 Antibiotic Drugs Manufacturers 2018


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ